|
|
|
|
|
by gattilorenz
1672 days ago
|
|
Not a virologist, infectivologist, etc. My understanding is that this virus has a mutated spike protein, i.e. a different "outside shell". This spike protein is what gives the virus its ability to attach to human cells, and also what most vaccines "expose" to your immune system to teach it how to recognize COVID-19. The difference in this variant's spike protein might have effect, among other things, on the ability of the immune system of a person that has been vaccinated to recognize the virus, so there's potential for a much decreased response/efficacy of the vaccines. However this is pure speculation at this point. Update: earlier this year it aws speculated that the beta mutation might have increased infectivity and/or the ability to better elude the immune response; that variant eventually died out, and delta is now the prevalent one. It might be a similar case, but it's hard to tell yet, and it's of course better to err on the side of caution. |
|